TITLE

WISDOM FROM BIG PHARMA'S DR. GLOOM

AUTHOR(S)
Lustgarten, Abrahm
PUB. DATE
March 2005
SOURCE
Fortune;3/21/2005, Vol. 151 Issue 6, p38
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents an interview with GlaxoSmithKline CEO Jean-Pierre Garnier. Thoughts on challenges facing the pharmaceutical industry, including the development of meaningful drugs; Signing with Human Genome Sciences to use gene sequencing technology to help develope new drugs; Comments on the antidepressant drug Paxil in light of claims that Paxil increases the likelihood of suicide in minors; Glaxo's budget for direct-to-consumer advertisements.
ACCESSION #
16352467

 

Related Articles

  • WISDOM FROM BIG PHARMA'S DR. GLOOM. Lustgarten, Abrahm // Fortune International (Europe);3/21/2005, Vol. 151 Issue 5, p20 

    Presents an interview with GlaxoSmithKline CEO Jean-Pierre Garnier. Thoughts on challenges facing the pharmaceutical industry, including the development of meaningful drugs; Signing with Human Genome Sciences to use gene sequencing technology to help develope new drugs; Comments on the...

  • SPEAKING OUT: JEAN-PIERRE GARNIER.  // Management Today;Mar2006, p14 

    The article presents the views of Jean-Pierre Garnier, CEO, GlaxoSmithKline (GSK), at the CBI Interactive Conference. Under his stewardship, GSK has streaked ahead with a pipeline of new drugs twice the size of its nearest competitor's. Garnier says innovation is all about people, but truly...

  • Good Science And The Marketplace For Drugs: A Conversation With Jean-Pierre Garnier. Iglehart, John K. // Health Affairs;Jul/Aug2003, Vol. 22 Issue 4, p119 

    Interviews Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline. Expansion of the scope of Medicare's prescription drug benefits; GlaxoSmithKline's drug research and development activities; Challenges posed by the generic market; Future of drug development.

  • Fat cat cream goes sour.  // European Chemical News;5/26/2003, Vol. 78 Issue 2054, p5 

    Comments on the decision of GlaxoSmithKline (GSK) shareholders to vote down the proposed remuneration package for chief executive officer Jean-Pierre Garnier. Amount of the proposed package; Argument of shareholders against the proposal; Implication of the GSK vote.

  • JP GARNIER. Davidson, Andrew // Management Today;Mar2004, p38 

    The French-born CEO Jean-Pierre Garnier of GlaxoSmithKline PLC has been pilloried for his huge salary demands, but he's not sorry. He and his executives will have earned their high rewards, he insists, if they deliver vital medicines to a world in dire need. Rebuilding its drugs pipeline is...

  • GSK makes strides in R&D.  // European Chemical News;12/8/2003, Vol. 79 Issue 2080, p28 

    Reports on the research and development (R&D) achievements of GlaxoSmithKline (GSK) presented by chief executive officer Jean-Pierre Garnier to investors in December 2003. Number of projects in clinical development; Number of chemical entities developed by GSK; R&D innovation launched by the...

  • Shareholders okay Garnier pay. Beacham, Will // European Chemical News;5/24/2004, Vol. 80 Issue 2101, p9 

    Reports on the approval of the compensation package of Jean-Pierre Garnier, the chief executive officer at GlaxoSmithKline, by shareholders at the British drug group's annual general meeting in May 2004. Value of the compensation package; Potential career changes at the company in 2004 and 2005.

  • TOP 10 COMPANIES AND THEIR CHIEFS.  // Management Today;Dec2003, p38 

    This article provides information about top 10 companies and their chiefs. some of them are, Sir Terry Leahy, Chief Executive of Tesco PLC. He is with the company since 1979 and ably steering the corporate trolley since March 1997, 47-year-old Leahy has made Tesco's position as the nation's...

  • IN SICKNESS AND IN WEALTH. Gwyther, Matthew // Management Today;Mar2004, p3 

    The article provides information related to several executives. There is something splendidly Gallic and irascible about Jean-Pierre Garnier, chief executive of GlaxoSmithKline PLC (GSK). Last year when he was caught up in one of the worst fat-cat pay rows in living memory, he blithely told...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics